Despite the substantial increase in sustainability reporting scholarly research, the comprehensive evaluation of scientific production in this area is scarce. This study combines the bibliometric and content analyses of sustainability reporting research to fill this gap. We map the development, conceptual structure, and thematic evolution of sustainability reporting scholarly research based on 1,053 Scopus peer-reviewed articles written by 2,071 scholars comprising 69 countries and published from 2000 to 2022. The findings suggest that sustainability reporting has witnessed exponential growth, moved from a “paucity” stage in 2000 to the “saturation” stage in 2022, and is still ongoing. The collaboration among institutions producing sustainability reporting research reflects “locally-centralized-globally-discrete” cooperation. The collaboration between developed and developing world research organizations can be termed the “North-South” divide. Authors have disciplinary or thematic similarities in their research interests (i.e., homophily impact). The study has explained the thematic categories and topics of interest in sustainability reporting. Based on our findings, we provide an agenda for future research directions. The study’s findings are of interest to scholars and practitioners in business, finance, and accounting.
Background
Venous thromboembolism is a significant clinical event, with an annual incidence of 1–2 per 1000 population. Risk factors include recent surgery, prolonged immobility, oral contraceptive use, and active cancer. Inherited risks include protein C and S deficiencies, antithrombin deficiency, factor V Leiden mutation and prothrombin. These factors can be tested to guide therapy, but current evidence suggests that testing for inherited thrombophilia is not recommended in most inpatient settings. In the era of high value care, hypercoagulable testing for VTE creates a financial burden for the hospital and patients. We performed a retrospective chart review of hypercoagulable orders on VTE patients at our institution.
Methods
Institutional Review Board approval was obtained. A total of 287 adult patients admitted over a 3-month period with the diagnosis of VTE were included. Patients were identified via ICD-10 codes and data were collected from electronic medical records. Patient characteristics, provoked versus unprovoked VTE, and relative contraindications for hypercoagulability work-up were analyzed. Our primary outcome was to assess the appropriateness of thrombophilia testing in VTE patients based on screening guidelines. Our secondary outcome was to analyze the cost burden of ordering these tests.
Results
A total of 287 patients were included in our data analysis. Patient risk factors for VTE were malignancy, previous DVT, immobilization, surgery 3 months prior, and central line placement. Fifty-seven of 287 patients had at least one hypercoagulable test ordered during hospitalization which did not adhere to guidelines. Misuse of testing occurred during active thrombosis, active anticoagulation, presence of risk factors, first episode of VTE, and malignancy. The cost of ordering these 5 thrombophilia tests totaled over $40,000.
Conclusion
In our study, numerous patients were tested without compliance to standard recommendations, which created financial and value-based burdens on our health care system. Increased awareness among clinicians is thus warranted to ensure high value care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.